Data gathered: December 1
Data Bits
Data Bits | Value / Change | Benchmark | |
---|---|---|---|
Job Posts | 138 -2.8% |
|
|
App downloads | N/A | N/A | |
Sentiment | 40 0% |
|
|
Webpage traffic | 43,000 -34.6% |
|
|
Employee Rating | 69 0% |
|
|
Google Trends | 34 -52.8% |
|
|
Linkedin Employees | 2,170 N/A |
|
|
Patents | 1,348 0.4% |
|
|
4chan Mentions | 0% | N/A | |
Facebook Engagement | 23 53.3% |
|
|
Facebook followers | 2,477 0% |
|
|
Stocktwits Mentions | 1 0% |
|
|
Stocktwits Subscribers | 1,356 0.1% |
|
|
Twitter Followers | 1,264 -0.1% |
|
|
Youtube Subscribers | 2,080 -0.5% |
|
|
Instagram Followers | 4,267 0.1% |
|
|
News Mentions | 0% |
|
|
Reddit Mentions | 0% |
|
|
Business outlook | 63 0% |
|
In the news
![]() |
Globus Medical: Merger Overhang LingeringNovember 27 - SeekingAlpha |
![]() |
Gracell Biotechnologies Shares Rise 9%, FDA Clears Application for Lupus TreatmentNovember 26 - MarketWatch |
RBC Capital Reaffirms Their Buy Rating on Globus Medical (GMED)November 23 - TipRanks |
|
Analysts Offer Insights on Healthcare Companies: Globus Medical (GMED) and LAVA Therapeutics (LVTX)November 20 - TipRanks |
|
Crispr Therapeutics, Vertex get world's first regulatory green light for CRISPR-based medicineNovember 15 - MarketWatch |
|
Globus Medical price target lowered to $53 from $60 at Morgan StanleyNovember 13 - Thefly.com |
About Globus Medical
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.

Price | $45.74 |
Target Price | Sign up |
Market Cap | $6.18B |
Dividend Yield | 0 |
Industry | Medical Devices |
Similar companies
Financial performance View All
Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | |
---|---|---|---|---|---|
Q3 '23 | 384M | 135M | 248M | 1,000,000 | 16M |
Q2 '23 | 292M | 76M | 215M | 58M | 71M |
Q1 '23 | 277M | 71M | 206M | 49M | 61M |
Q4 '22 | 274M | 71M | 204M | 50M | 59M |
Q3 '22 | 254M | 65M | 189M | 47M | 64M |
Insider Transactions
Lemaitre Dan filed to sell 10,800 shares at $57. May 17 '23 |